Aspira Pathlab & Diagnostics Ltd
BSE:540788
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aspira Pathlab & Diagnostics Ltd
BSE:540788
|
IN |
|
Epwin Group PLC
LSE:EPWN
|
UK |
|
Henan Tong-Da Cable Co Ltd
SZSE:002560
|
CN |
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
UK |
|
BAIC BluePark New Energy Technology Co Ltd
SSE:600733
|
CN |
|
S
|
Suzhou Fushilai Pharmaceutical Co Ltd
SZSE:301258
|
CN |
|
NextSource Materials Inc
TSX:NEXT
|
CA |
|
Usen Next Holdings Co Ltd
TSE:9418
|
JP |
|
Takara Leben Real Estate Investment Corp
TSE:3492
|
JP |
|
7Road Holdings Ltd
HKEX:797
|
CN |
|
Dream Impact Trust
TSX:MPCT.UN
|
CA |
|
Kourakuen Holdings Corp
TSE:7554
|
JP |
|
Porr AG
LSE:0J04
|
AT |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
|
IN |
Discount Rate
ASPIRA Cost of Equity
Discount Rate
ASPIRA's Cost of Equity, calculated using the formula
Risk-Free Rate + Beta x ERP,
stands at 10.49%.
The Beta, indicating the stock's volatility relative to the market, is 0.91, while the current Risk-Free Rate, based on government bond yields, is 6.69%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
ASPIRA WACC
Discount Rate
ASPIRA's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax.
The WACC stands at 10.68%. This includes the cost of equity at 10.49%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 15.59%, reflecting the interest rate on
ASPIRA's debt adjusted for tax benefits. The weight of debt in the capital structure is 3.68%.
What is ASPIRA's discount rate?
ASPIRA
's current Cost of Equity is 10.49%, while its WACC stands at 10.68%.
The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."
How is Cost of Equity for ASPIRA calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
ASPIRA
How is WACC for ASPIRA calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
ASPIRA
